Tumor rejection antigen precursors, tumor rejection antigens and uses thereof
US5925729A · kind A · utility
20Cited by
3References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 2, 1994 |
| Grant date | Jul 20, 1999 |
| Priority date | — |
| Expiry date | May 2, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/828
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to an isolated DNA sequence which codes for an antigen expressed by tumor cells which is recognized by cytotoxic T cells, leading to lysis of the tumor which expresses it. Also described are cells transfected by the DNA sequence, and various therapeutic and diagnostic uses arising out of the properties of the DNA and the antigen for which it codes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.